Inventor · disambiguated record
Marcio Luis Andrade E Silva
Also filed as: SILVA MARCIO LUIS ANDRADE · SILVA MARCIO LUIS ANDRADE E · SILVA MÁRCIO LUÍS ANDRADE E
3 granted patents·2 pending applications·0 citations·filing 2003–2009
45Inventor score
Files withFUNDACAO DE AMPARO A PESQUISA2ALBUQUERQUE SÉRGIO1FUNDACADO DE AMPARO A PESQUISA1FUNDACAO DE AMPARO A PESQUISSA1
Top patents by PatentIndex Score
5 records- 0150US8829049B2Medicinal composition intended for the treatment of erectile dysfunction in mammals and use of the compositionALBUQUERQUE SÉRGIO·Filed 2009·Granted Sep 9, 2014·0 cites·7 claims
- 0247US7521569B2Process to obtain dibenzylbutyrolactonic lignans, process to obtain synthetic derivatives from lignans bearing anti-Chagas chemoprophylactic and therapeutical activitiesFUNDACAO DE AMPARO A PESQUISA·Filed 2007·Granted Apr 21, 2009·0 cites·2 claims
- 0337US7317114B2Process to obtain dibenzylbutyrolactonic lignans, process to obtain synthetic derivatives from lignans bearing anti-Chagas chemoprophylactic and therapeutical activitiesFUNDACAO DE AMPARO A PESQUISA·Filed 2003·Granted Jan 8, 2008·0 cites·4 claims
- 0430US2008194678A1Process To Obtain Synthetic And Semi-Synthetic Lignan Derivatives, Their Antiparasitic Activities And Corresponding Pharmaceutical Formulations, Including The Therapeutic Method Using Said Lignan For The Treatment Of ParasitosisFUNDACAO DE AMPARO A PESQUISSA·Filed 2006·Application pending·0 cites
- 0528US2008214661A1Process To Obtain Dibenzylbutyrolactonic, Tetrahydrofuranic Lignans And Their Synthetic And Semi-Synthetic Derivatives, Their Analgesic And Anti-Inflammatory Activities, Topical And/Or Systemic Formulations Containing Said Lignans And Their Respective Therapeutic MethodFUNDACADO DE AMPARO A PESQUISA·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marcio Luis Andrade E Silva files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →